Decitabine

5 WARNINGS AND PRECAUTIONS Neutropenia and Thrombocytopenia: Perform complete blood counts and platelet counts. ( 5.1 ) Embryo-Fetal Toxicity: Can cause fetal harm. Advise patients of reproductive potential of the potential risk to a fetus and to use effective contraception ( 5.2 , 8.1 , 8.3 ) 5.1 Myelosuppression Fatal and serious myelosuppression occurs in Decitabine for Injection -treated patients. Myelosuppression (anemia, neutropenia, and thrombocytopenia) is the most frequent cause of Decitabine for Injection dose reduction, delay, and discontinuation. Neutropenia of any grade occurred in 90% of Decitabine for Injection-treated patients with grade 3 or 4 occurring in 87% of patients. Grade 3 or 4 febrile neutropenia occurred in 23% of patients. Thrombocytopenia of any grade occurred in 89% of patients with grade 3 or 4 occurring in 85% of patients. Anemia of any grade occurred in 82% of patients. Perform complete blood count with platelets at baseline, prior to each cycle, and as needed to monitor response and toxicity. Manage toxicity using dose-delay, dose-reduction, growth factors, and anti-infective therapies as needed [see Dosage and Administration (2.2) ] . Myelosuppression and worsening neutropenia may occur more frequently in the first or second treatment cycles and may not necessarily indicate progression of underlying MDS. 5.2 Embryo-Fetal Toxicity Based on findings from human data, animal studies and its mechanism of action, Decitabine for Injection can cause fetal harm when administered to a pregnant woman [see Clinical Pharmacology (12.1) and Nonclinical Toxicology (13.1) ] . In preclinical studies in mice and rats, decitabine caused adverse developmental outcomes including embryo-fetal lethality and malformations. Advise pregnant women of the potential risk to a fetus. Advise females of reproductive potential to use effective contraception while receiving Decitabine for Injection and for 6 months following the last dose. Advise males with female partners of reproductive potential to use effective contraception while receiving treatment with Decitabine for Injection and for 3 months following the last dose [see Use in Specific Populations (8.1 , 8.3) ] .

6 ADVERSE REACTIONS The following clinically significant adverse reactions are described elsewhere in the labeling: Myelosuppression [see Warnings and Precautions (5.1) ] Most common adverse reactions (> 50%) are neutropenia, thrombocytopenia, anemia, and pyrexia. ( 6.1 ) To report SUSPECTED ADVERSE REACTIONS, contact Accord Healthcare Inc. at 1-866-941-7875 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. The safety of Decitabine for Injection was studied in 3 single-arm studies (N = 66, N = 98, N = 99) and 1 controlled supportive care study (N = 83 Decitabine for Injection, N = 81 supportive care). The data described below reflect exposure to Decitabine for Injection in 83 patients in the MDS trial. In the trial, patients received 15 mg/m 2 intravenously every 8 hours for 3 days every 6 weeks. The median number of Decitabine for Injection cycles was 3 (range 0 to 9). Most Common Adverse Reactions: neutropenia, thrombocytopenia, anemia, fatigue, pyrexia, nausea, cough, petechiae, constipation, diarrhea, and hyperglycemia. Adverse Reactions Most Frequently (≥ 1%) Resulting in Clinical Intervention and or Dose Modification in the Controlled Supportive Care Study in the decitabine Arm: Discontinuation: thrombocytopenia, neutropenia, pneumonia, Mycobacterium avium complex infection, cardio-respiratory arrest, increased blood bilirubin, intracranial hemorrhage, abnormal liver function tests. Dose Delayed: neutropenia, pulmonary edema, atrial fibrillation, central line infection, febrile neutropenia. Dose Reduced: neutropenia, thrombocytopenia, anemia, lethargy, edema, tachycardia, depression, pharyngitis. Table 1 presents all adverse reactions occurring in at least 5% of patients in the decitabine group and at a rate greater than supportive care. Table 1 Adverse Reactions Reported in ≥ 5% of Patients in the decitabine Group and at a Rate Greater than Supportive Care in the Controlled Trial in MDS Decitabine N = 83 (%) Supportive Care N = 81 (%) Blood and lymphatic system disorders Neutropenia 75 (90) 58 (72) Thrombocytopenia 74 (89) 64 (79) Anemia NOS 68 (82) 60 (74) Febrile neutropenia 24 (29) 5 (6) Leukopenia NOS 23 (28) 11 (14) Lymphadenopathy 10 (12) 6 (7) Thrombocythemia 4 (5) 1 (1) Cardiac disorders Pulmonary edema NOS 5 (6) 0 (0) Eye disorders Vision blurred 5 (6) 0 (0) Gastrointestinal disorders Nausea 35 (42) 13 (16) Constipation 29 (35) 11 (14) Diarrhea NOS 28 (34) 13 (16) Vomiting NOS 21 (25) 7 (9) Abdominal pain NOS 12 (14) 5 (6) Oral mucosal petechiae 11 (13) 4 (5) Stomatitis 10 (12) 5 (6) Dyspepsia 10 (12) 1 (1) Ascites 8 (10) 2 (2) Gingival bleeding 7 (8) 5 (6) Hemorrhoids 7 (8) 3 (4) Loose stools 6 (7) 3 (4) Tongue ulceration 6 (7) 2 (2) Dysphagia 5 (6) 2 (2) Oral soft tissue disorder NOS 5 (6) 1 (1) Lip ulceration 4 (5) 3 (4) Abdominal distension 4 (5) 1 (1) Abdominal pain upper 4 (5) 1 (1) Gastro-esophageal reflux disease 4 (5) 0 (0) Glossodynia 4 (5) 0 (0) General disorders and administrative site disorders Pyrexia 44 (53) 23 (28) Edema peripheral 21 (25) 13 (16) Rigors 18 (22) 14 (17) Edema NOS 15 (18) 5 (6) Pain NOS 11 (13) 5 (6) Lethargy 10 (12) 3 (4) Tenderness NOS 9 (11) 0 (0) Fall 7 (8) 3 (4) Chest discomfort 6 (7) 3 (4) Intermittent pyrexia 5 (6) 3 (4) Malaise 4 (5) 1 (1) Crepitations NOS 4 (5) 1 (1) Catheter site erythema 4 (5) 1 (1) Catheter site pain 4 (5) 0 (0) Injection site swelling 4 (5) 0 (0) Hepatobiliary disorders Hyperbilirubinemia 12 (14) 4 (5) Infections and infestations Pneumonia NOS 18 (22) 11 (14) Cellulitis 10 (12) 6 (7) Candidal infection NOS 8 (10) 1 (1) Catheter related infection 7 (8) 0 (0) Urinary tract infection NOS 6 (7) 1 (1) Staphylococcal infection 6 (7) 0 (0) Oral candidiasis 5 (6) 2 (2) Sinusitis NOS 4 (5) 2 (2) Bacteremia 4 (5) 0 (0) Injury, poisoning and procedural complications Transfusion reaction 6 (7) 3 (4) Abrasion NOS 4 (5) 1 (1) Investigations Cardiac murmur NOS 13 (16) 9 (11) Blood alkaline phosphatase NOS increased 9 (11) 7 (9) Aspartate aminotransferase increased 8 (10) 7 (9) Blood urea increased 8 (10) 1 (1) Blood lactate dehydrogenase increased 7 (8) 5 (6) Blood albumin decreased 6 (7) 0 (0) Blood bicarbonate increased 5 (6) 1 (1) Blood chloride decreased 5 (6) 1 (1) Protein total decreased 4 (5) 3 (4) Blood bicarbonate decreased 4 (5) 1 (1) Blood bilirubin decreased 4 (5) 1 (1) Metabolism and nutrition disorders Hyperglycemia NOS 27 (33) 16 (20) Hypoalbuminemia 20 (24) 14 (17) Hypomagnesemia 20 (24) 6 (7) Hypokalemia 18 (22) 10 (12) Hyponatremia 16 (19) 13 (16) Appetite decreased NOS 13 (16) 12 (15) Anorexia 13 (16) 8 (10) Hyperkalemia 11 (13) 3 (4) Dehydration 5 (6) 4 (5) Musculoskeletal and connective tissue disorders Arthralgia 17 (20) 8 (10) Pain in limb 16 (19) 8 (10) Back pain 14 (17) 5 (6) Chest wall pain 6 (7) 1 (1) Musculoskeletal discomfort 5 (6) 0 (0) Myalgia 4 (5) 1 (1) Nervous system disorders Headache 23 (28) 11 (14) Dizziness 15 (18) 10 (12) Hypoesthesia 9 (11) 1 (1) Psychiatric disorders Insomnia 23 (28) 11 (14) Confusional state 10 (12) 3 (4) Anxiety 9 (11) 8 (10) Renal and urinary disorders Dysuria 5 (6) 3 (4) Urinary frequency 4 (5) 1 (1) Respiratory, thoracic and Mediastinal disorders Cough 33 (40) 25 (31) Pharyngitis 13 (16) 6 (7) Crackles lung 12 (14) 1 (1) Breath sounds decreased 8 (10) 7 (9) Hypoxia 8 (10) 4 (5) Rales 7 (8) 2 (2) Postnasal drip 4 (5) 2 (2) Skin and subcutaneous tissue disorders Ecchymosis 18 (22) 12 (15) Rash NOS 16 (19) 7 (9) Erythema 12 (14) 5 (6) Skin lesion NOS 9 (11) 3 (4) Pruritis 9 (11) 2 (2) Alopecia 7 (8) 1 (1) Urticaria NOS 5 (6) 1 (1) Swelling face 5 (6) 0 (0) Vascular disorders Petechiae 32 (39) 13 (16) Pallor 19 (23) 10 (12) Hypotension NOS 5 (6) 4 (5) Hematoma NOS 4 (5) 3 (4) In a single-arm MDS study (N=99), Decitabine was dosed at 20 mg/m 2 intravenously, infused over one hour daily for 5 consecutive days of a 4-week cycle. Table 2 presents all adverse reactions occurring in at least 5% of patients. Table 2 Adverse Reactions Reported in ≥ 5% of Patients in a Single-arm Study * Decitabine N = 99 (%) Blood and lymphatic system disorders Anemia 31 (31) Febrile neutropenia 20 (20) Leukopenia 6 (6) Neutropenia 38 (38) Pancytopenia 5 (5) Thrombocythemia 5 (5) Thrombocytopenia 27 (27) Cardiac disorders Cardiac failure congestive 5 (5) Tachycardia 8 (8) Ear and labyrinth disorders Ear pain 6 (6) Gastrointestinal disorders Abdominal pain 14 (14) Abdominal pain upper 6 (6) Constipation 30 (30) Diarrhea 28 (28) Dyspepsia 10 (10) Dysphagia 5 (5) Gastro-esophageal reflux disease 5 (5) Nausea 40 (40) Oral pain 5 (5) Stomatitis 11 (11) Toothache 6 (6) Vomiting 16 (16) General disorders and administration site conditions Asthenia 15 (15) Chest pain 6 (6) Chills 16 (16) Fatigue 46 (46) Mucosal inflammation 9 (9) Edema 5 (5) Edema peripheral 27 (27) Pain 5 (5) Pyrexia 36 (36) Infections and infestations Cellulitis 9 (9) Oral candidiasis 6 (6) Pneumonia 20 (20) Sinusitis 6 (6) Staphylococcal bacteremia 8 (8) Tooth abscess 5 (5) Upper respiratory tract infection 10 (10) Urinary tract infection 7 (7) Injury, poisoning and procedural complications Contusion 9 (9) Investigations Blood bilirubin increased 6 (6) Breath sounds abnormal 5 (5) Weight decreased 9 (9) Metabolism and nutrition disorders Anorexia 23 (23) Decreased appetite 8 (8) Dehydration 8 (8) Hyperglycemia 6 (6) Hypokalemia 12 (12) Hypomagnesemia 5 (5) Musculoskeletal and connective tissue disorders Arthralgia 17 (17) Back pain 18 (18) Bone pain 6 (6) Muscle spasms 7 (7) Muscular weakness 5 (5) Musculoskeletal pain 5 (5) Myalgia 9 (9) Pain in extremity 18 (18) Nervous system disorders Dizziness 21 (21) Headache 23 (23) Psychiatric disorders Anxiety 9 (9) Confusional state 8 (8) Depression 9 (9) Insomnia 14 (14) Respiratory, thoracic and mediastinal disorders Cough 27 (27) Dyspnea 29 (29) Epistaxis 13 (13) Pharyngolaryngeal pain 8 (8) Pleural effusion 5 (5) Sinus congestion 5 (5) Skin and subcutaneous tissue disorders Dry skin 8 (8) Ecchymosis 9 (9) Erythema 5 (5) Night sweats 5 (5) Petechiae 12 (12) Pruritus 9 (9) Rash 11 (11) Skin lesion 5 (5) Vascular disorders Hypertension 6 (6) Hypotension 11 (11) * In this single arm study, investigators reported adverse events based on clinical signs and symptoms rather than predefined laboratory abnormalities. Thus, not all laboratory abnormalities were recorded as adverse events. No overall difference in safety was detected between patients > 65 years of age and younger patients in these MDS trials. No significant differences in safety were detected between males and females. Patients with renal or hepatic dysfunction were not studied. Insufficient numbers of non-White patients were available to draw conclusions in these clinical trials. Serious adverse reactions that occurred in patients receiving decitabine not previously reported in Tables 1 and 2 include: Allergic Reaction: hypersensitivity (anaphylactic reaction) Blood and Lymphatic System Disorders: myelosuppression, splenomegaly Cardiac Disorders: myocardial infarction, cardio-respiratory arrest, cardiomyopathy, atrial fibrillation, supraventricular tachycardia Gastrointestinal Disorders: gingival pain, upper gastrointestinal hemorrhage General Disorders and Administrative Site Conditions: chest pain, catheter site hemorrhage Hepatobiliary Disorders: cholecystitis Infections and Infestations: fungal infection, sepsis, bronchopulmonary aspergillosis, peridiverticular abscess, respiratory tract infection, pseudomonal lung infection, Mycobacterium avium complex infection Injury, Poisoning and Procedural Complications: post procedural pain, post procedural hemorrhage Nervous System Disorders: intracranial hemorrhage Psychiatric Disorders: mental status changes Renal and Urinary Disorders: renal failure, urethral hemorrhage Respiratory, Thoracic and Mediastinal Disorders: hemoptysis, lung infiltration, pulmonary embolism, respiratory arrest, pulmonary mass 6.2 Postmarketing Experience The following adverse reactions have been identified during postapproval use of decitabine. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. Sweet's syndrome (acute febrile neutrophilic dermatosis) Differentiation syndrome Interstitial lung disease

<table width="80%"><caption>Table 1 Adverse Reactions Reported in &#x2265; 5% of Patients in the decitabine Group and at a Rate Greater than Supportive Care in the Controlled Trial in MDS</caption><col align="left" width="33%"/><col align="center" width="33%"/><col align="center" width="33%"/><thead><tr><th align="center" styleCode="Botrule Lrule Rrule"/><th align="center" styleCode="Botrule Lrule Rrule">Decitabine N = 83 (%) </th><th align="center" styleCode="Botrule Lrule Rrule">Supportive Care N = 81 (%) </th></tr></thead><tbody><tr><td colspan="3" styleCode="Botrule Lrule Rrule"><content styleCode="bold">Blood and lymphatic system disorders</content></td></tr><tr><td styleCode="Botrule Lrule Rrule">Neutropenia</td><td styleCode="Botrule Lrule Rrule">75 (90)</td><td styleCode="Botrule Lrule Rrule">58 (72)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Thrombocytopenia</td><td styleCode="Botrule Lrule Rrule">74 (89)</td><td styleCode="Botrule Lrule Rrule">64 (79)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Anemia NOS</td><td styleCode="Botrule Lrule Rrule">68 (82)</td><td styleCode="Botrule Lrule Rrule">60 (74)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Febrile neutropenia</td><td styleCode="Botrule Lrule Rrule">24 (29)</td><td styleCode="Botrule Lrule Rrule">5 (6)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Leukopenia NOS</td><td styleCode="Botrule Lrule Rrule">23 (28)</td><td styleCode="Botrule Lrule Rrule">11 (14)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Lymphadenopathy</td><td styleCode="Botrule Lrule Rrule">10 (12)</td><td styleCode="Botrule Lrule Rrule">6 (7)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Thrombocythemia</td><td styleCode="Botrule Lrule Rrule">4 (5)</td><td styleCode="Botrule Lrule Rrule">1 (1)</td></tr><tr><td colspan="3" styleCode="Botrule Lrule Rrule"><content styleCode="bold">Cardiac disorders</content></td></tr><tr><td styleCode="Botrule Lrule Rrule">Pulmonary edema NOS</td><td styleCode="Botrule Lrule Rrule">5 (6)</td><td styleCode="Botrule Lrule Rrule">0 (0)</td></tr><tr><td colspan="3" styleCode="Botrule Lrule Rrule"><content styleCode="bold">Eye disorders</content></td></tr><tr><td styleCode="Botrule Lrule Rrule">Vision blurred</td><td styleCode="Botrule Lrule Rrule">5 (6)</td><td styleCode="Botrule Lrule Rrule">0 (0)</td></tr><tr><td colspan="3" styleCode="Botrule Lrule Rrule"><content styleCode="bold">Gastrointestinal disorders</content></td></tr><tr><td styleCode="Botrule Lrule Rrule">Nausea</td><td styleCode="Botrule Lrule Rrule">35 (42)</td><td styleCode="Botrule Lrule Rrule">13 (16)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Constipation</td><td styleCode="Botrule Lrule Rrule">29 (35)</td><td styleCode="Botrule Lrule Rrule">11 (14)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Diarrhea NOS</td><td styleCode="Botrule Lrule Rrule">28 (34)</td><td styleCode="Botrule Lrule Rrule">13 (16)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Vomiting NOS</td><td styleCode="Botrule Lrule Rrule">21 (25)</td><td styleCode="Botrule Lrule Rrule">7 (9)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Abdominal pain NOS</td><td styleCode="Botrule Lrule Rrule">12 (14)</td><td styleCode="Botrule Lrule Rrule">5 (6)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Oral mucosal petechiae</td><td styleCode="Botrule Lrule Rrule">11 (13)</td><td styleCode="Botrule Lrule Rrule">4 (5)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Stomatitis</td><td styleCode="Botrule Lrule Rrule">10 (12)</td><td styleCode="Botrule Lrule Rrule">5 (6)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Dyspepsia</td><td styleCode="Botrule Lrule Rrule">10 (12)</td><td styleCode="Botrule Lrule Rrule">1 (1)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Ascites</td><td styleCode="Botrule Lrule Rrule">8 (10)</td><td styleCode="Botrule Lrule Rrule">2 (2)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Gingival bleeding</td><td styleCode="Botrule Lrule Rrule">7 (8)</td><td styleCode="Botrule Lrule Rrule">5 (6)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Hemorrhoids</td><td styleCode="Botrule Lrule Rrule">7 (8)</td><td styleCode="Botrule Lrule Rrule">3 (4)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Loose stools</td><td styleCode="Botrule Lrule Rrule">6 (7)</td><td styleCode="Botrule Lrule Rrule">3 (4)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Tongue ulceration</td><td styleCode="Botrule Lrule Rrule">6 (7)</td><td styleCode="Botrule Lrule Rrule">2 (2)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Dysphagia</td><td styleCode="Botrule Lrule Rrule">5 (6)</td><td styleCode="Botrule Lrule Rrule">2 (2)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Oral soft tissue disorder NOS</td><td styleCode="Botrule Lrule Rrule">5 (6)</td><td styleCode="Botrule Lrule Rrule">1 (1)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Lip ulceration</td><td styleCode="Botrule Lrule Rrule">4 (5)</td><td styleCode="Botrule Lrule Rrule">3 (4)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Abdominal distension</td><td styleCode="Botrule Lrule Rrule">4 (5)</td><td styleCode="Botrule Lrule Rrule">1 (1)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Abdominal pain upper</td><td styleCode="Botrule Lrule Rrule">4 (5)</td><td styleCode="Botrule Lrule Rrule">1 (1)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Gastro-esophageal reflux disease</td><td styleCode="Botrule Lrule Rrule">4 (5)</td><td styleCode="Botrule Lrule Rrule">0 (0)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Glossodynia</td><td styleCode="Botrule Lrule Rrule">4 (5)</td><td styleCode="Botrule Lrule Rrule">0 (0)</td></tr><tr><td colspan="3" styleCode="Botrule Lrule Rrule"><content styleCode="bold">General disorders and administrative site disorders</content></td></tr><tr><td styleCode="Botrule Lrule Rrule">Pyrexia</td><td styleCode="Botrule Lrule Rrule">44 (53)</td><td styleCode="Botrule Lrule Rrule">23 (28)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Edema peripheral</td><td styleCode="Botrule Lrule Rrule">21 (25)</td><td styleCode="Botrule Lrule Rrule">13 (16)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Rigors</td><td styleCode="Botrule Lrule Rrule">18 (22)</td><td styleCode="Botrule Lrule Rrule">14 (17)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Edema NOS</td><td styleCode="Botrule Lrule Rrule">15 (18)</td><td styleCode="Botrule Lrule Rrule">5 (6)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Pain NOS</td><td styleCode="Botrule Lrule Rrule">11 (13)</td><td styleCode="Botrule Lrule Rrule">5 (6)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Lethargy</td><td styleCode="Botrule Lrule Rrule">10 (12)</td><td styleCode="Botrule Lrule Rrule">3 (4)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Tenderness NOS</td><td styleCode="Botrule Lrule Rrule">9 (11)</td><td styleCode="Botrule Lrule Rrule">0 (0)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Fall</td><td styleCode="Botrule Lrule Rrule">7 (8)</td><td styleCode="Botrule Lrule Rrule">3 (4)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Chest discomfort</td><td styleCode="Botrule Lrule Rrule">6 (7)</td><td styleCode="Botrule Lrule Rrule">3 (4)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Intermittent pyrexia</td><td styleCode="Botrule Lrule Rrule">5 (6)</td><td styleCode="Botrule Lrule Rrule">3 (4)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Malaise</td><td styleCode="Botrule Lrule Rrule">4 (5)</td><td styleCode="Botrule Lrule Rrule">1 (1)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Crepitations NOS</td><td styleCode="Botrule Lrule Rrule">4 (5)</td><td styleCode="Botrule Lrule Rrule">1 (1)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Catheter site erythema</td><td styleCode="Botrule Lrule Rrule">4 (5)</td><td styleCode="Botrule Lrule Rrule">1 (1)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Catheter site pain</td><td styleCode="Botrule Lrule Rrule">4 (5)</td><td styleCode="Botrule Lrule Rrule">0 (0)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Injection site swelling</td><td styleCode="Botrule Lrule Rrule">4 (5)</td><td styleCode="Botrule Lrule Rrule">0 (0)</td></tr><tr><td colspan="3" styleCode="Botrule Lrule Rrule"><content styleCode="bold">Hepatobiliary disorders</content></td></tr><tr><td styleCode="Botrule Lrule Rrule">Hyperbilirubinemia</td><td styleCode="Botrule Lrule Rrule">12 (14)</td><td styleCode="Botrule Lrule Rrule">4 (5)</td></tr><tr><td colspan="3" styleCode="Botrule Lrule Rrule"><content styleCode="bold">Infections and infestations</content></td></tr><tr><td styleCode="Botrule Lrule Rrule">Pneumonia NOS</td><td styleCode="Botrule Lrule Rrule">18 (22)</td><td styleCode="Botrule Lrule Rrule">11 (14)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Cellulitis</td><td styleCode="Botrule Lrule Rrule">10 (12)</td><td styleCode="Botrule Lrule Rrule">6 (7)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Candidal infection NOS</td><td styleCode="Botrule Lrule Rrule">8 (10)</td><td styleCode="Botrule Lrule Rrule">1 (1)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Catheter related infection</td><td styleCode="Botrule Lrule Rrule">7 (8)</td><td styleCode="Botrule Lrule Rrule">0 (0)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Urinary tract infection NOS</td><td styleCode="Botrule Lrule Rrule">6 (7)</td><td styleCode="Botrule Lrule Rrule">1 (1)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Staphylococcal infection</td><td styleCode="Botrule Lrule Rrule">6 (7)</td><td styleCode="Botrule Lrule Rrule">0 (0)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Oral candidiasis</td><td styleCode="Botrule Lrule Rrule">5 (6)</td><td styleCode="Botrule Lrule Rrule">2 (2)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Sinusitis NOS</td><td styleCode="Botrule Lrule Rrule">4 (5)</td><td styleCode="Botrule Lrule Rrule">2 (2)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Bacteremia</td><td styleCode="Botrule Lrule Rrule">4 (5)</td><td styleCode="Botrule Lrule Rrule">0 (0)</td></tr><tr><td colspan="3" styleCode="Botrule Lrule Rrule"><content styleCode="bold">Injury, poisoning and procedural complications</content></td></tr><tr><td styleCode="Botrule Lrule Rrule">Transfusion reaction</td><td styleCode="Botrule Lrule Rrule">6 (7)</td><td styleCode="Botrule Lrule Rrule">3 (4)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Abrasion NOS</td><td styleCode="Botrule Lrule Rrule">4 (5)</td><td styleCode="Botrule Lrule Rrule">1 (1)</td></tr><tr><td colspan="3" styleCode="Botrule Lrule Rrule"><content styleCode="bold">Investigations</content></td></tr><tr><td styleCode="Botrule Lrule Rrule">Cardiac murmur NOS</td><td styleCode="Botrule Lrule Rrule">13 (16)</td><td styleCode="Botrule Lrule Rrule">9 (11)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Blood alkaline phosphatase NOS increased</td><td styleCode="Botrule Lrule Rrule">9 (11)</td><td styleCode="Botrule Lrule Rrule">7 (9)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Aspartate aminotransferase increased</td><td styleCode="Botrule Lrule Rrule">8 (10)</td><td styleCode="Botrule Lrule Rrule">7 (9)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Blood urea increased</td><td styleCode="Botrule Lrule Rrule">8 (10)</td><td styleCode="Botrule Lrule Rrule">1 (1)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Blood lactate dehydrogenase increased</td><td styleCode="Botrule Lrule Rrule">7 (8)</td><td styleCode="Botrule Lrule Rrule">5 (6)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Blood albumin decreased</td><td styleCode="Botrule Lrule Rrule">6 (7)</td><td styleCode="Botrule Lrule Rrule">0 (0)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Blood bicarbonate increased</td><td styleCode="Botrule Lrule Rrule">5 (6)</td><td styleCode="Botrule Lrule Rrule">1 (1)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Blood chloride decreased</td><td styleCode="Botrule Lrule Rrule">5 (6)</td><td styleCode="Botrule Lrule Rrule">1 (1)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Protein total decreased</td><td styleCode="Botrule Lrule Rrule">4 (5)</td><td styleCode="Botrule Lrule Rrule">3 (4)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Blood bicarbonate decreased</td><td styleCode="Botrule Lrule Rrule">4 (5)</td><td styleCode="Botrule Lrule Rrule">1 (1)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Blood bilirubin decreased</td><td styleCode="Botrule Lrule Rrule">4 (5)</td><td styleCode="Botrule Lrule Rrule">1 (1)</td></tr><tr><td colspan="3" styleCode="Botrule Lrule Rrule"><content styleCode="bold">Metabolism and nutrition disorders</content></td></tr><tr><td styleCode="Botrule Lrule Rrule">Hyperglycemia NOS</td><td styleCode="Botrule Lrule Rrule">27 (33)</td><td styleCode="Botrule Lrule Rrule">16 (20)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Hypoalbuminemia</td><td styleCode="Botrule Lrule Rrule">20 (24)</td><td styleCode="Botrule Lrule Rrule">14 (17)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Hypomagnesemia</td><td styleCode="Botrule Lrule Rrule">20 (24)</td><td styleCode="Botrule Lrule Rrule">6 (7)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Hypokalemia</td><td styleCode="Botrule Lrule Rrule">18 (22)</td><td styleCode="Botrule Lrule Rrule">10 (12)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Hyponatremia</td><td styleCode="Botrule Lrule Rrule">16 (19)</td><td styleCode="Botrule Lrule Rrule">13 (16)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Appetite decreased NOS</td><td styleCode="Botrule Lrule Rrule">13 (16)</td><td styleCode="Botrule Lrule Rrule">12 (15)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Anorexia</td><td styleCode="Botrule Lrule Rrule">13 (16)</td><td styleCode="Botrule Lrule Rrule">8 (10)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Hyperkalemia</td><td styleCode="Botrule Lrule Rrule">11 (13)</td><td styleCode="Botrule Lrule Rrule">3 (4)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Dehydration</td><td styleCode="Botrule Lrule Rrule">5 (6)</td><td styleCode="Botrule Lrule Rrule">4 (5)</td></tr><tr><td colspan="3" styleCode="Botrule Lrule Rrule"><content styleCode="bold">Musculoskeletal and connective tissue disorders</content></td></tr><tr><td styleCode="Botrule Lrule Rrule">Arthralgia</td><td styleCode="Botrule Lrule Rrule">17 (20)</td><td styleCode="Botrule Lrule Rrule">8 (10)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Pain in limb</td><td styleCode="Botrule Lrule Rrule">16 (19)</td><td styleCode="Botrule Lrule Rrule">8 (10)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Back pain</td><td styleCode="Botrule Lrule Rrule">14 (17)</td><td styleCode="Botrule Lrule Rrule">5 (6)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Chest wall pain</td><td styleCode="Botrule Lrule Rrule">6 (7)</td><td styleCode="Botrule Lrule Rrule">1 (1)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Musculoskeletal discomfort</td><td styleCode="Botrule Lrule Rrule">5 (6)</td><td styleCode="Botrule Lrule Rrule">0 (0)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Myalgia</td><td styleCode="Botrule Lrule Rrule">4 (5)</td><td styleCode="Botrule Lrule Rrule">1 (1)</td></tr><tr><td colspan="3" styleCode="Botrule Lrule Rrule"><content styleCode="bold">Nervous system disorders</content></td></tr><tr><td styleCode="Botrule Lrule Rrule">Headache</td><td styleCode="Botrule Lrule Rrule">23 (28)</td><td styleCode="Botrule Lrule Rrule">11 (14)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Dizziness</td><td styleCode="Botrule Lrule Rrule">15 (18)</td><td styleCode="Botrule Lrule Rrule">10 (12)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Hypoesthesia</td><td styleCode="Botrule Lrule Rrule">9 (11)</td><td styleCode="Botrule Lrule Rrule">1 (1)</td></tr><tr><td colspan="3" styleCode="Botrule Lrule Rrule"><content styleCode="bold">Psychiatric disorders</content></td></tr><tr><td styleCode="Botrule Lrule Rrule">Insomnia</td><td styleCode="Botrule Lrule Rrule">23 (28)</td><td styleCode="Botrule Lrule Rrule">11 (14)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Confusional state</td><td styleCode="Botrule Lrule Rrule">10 (12)</td><td styleCode="Botrule Lrule Rrule">3 (4)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Anxiety</td><td styleCode="Botrule Lrule Rrule">9 (11)</td><td styleCode="Botrule Lrule Rrule">8 (10)</td></tr><tr><td colspan="3" styleCode="Botrule Lrule Rrule"><content styleCode="bold">Renal and urinary disorders</content></td></tr><tr><td styleCode="Botrule Lrule Rrule">Dysuria</td><td styleCode="Botrule Lrule Rrule">5 (6)</td><td styleCode="Botrule Lrule Rrule">3 (4)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Urinary frequency</td><td styleCode="Botrule Lrule Rrule">4 (5)</td><td styleCode="Botrule Lrule Rrule">1 (1)</td></tr><tr><td colspan="3" styleCode="Botrule Lrule Rrule"><content styleCode="bold">Respiratory, thoracic and Mediastinal disorders</content></td></tr><tr><td styleCode="Botrule Lrule Rrule">Cough</td><td styleCode="Botrule Lrule Rrule">33 (40)</td><td styleCode="Botrule Lrule Rrule">25 (31)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Pharyngitis</td><td styleCode="Botrule Lrule Rrule">13 (16)</td><td styleCode="Botrule Lrule Rrule">6 (7)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Crackles lung</td><td styleCode="Botrule Lrule Rrule">12 (14)</td><td styleCode="Botrule Lrule Rrule">1 (1)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Breath sounds decreased</td><td styleCode="Botrule Lrule Rrule">8 (10)</td><td styleCode="Botrule Lrule Rrule">7 (9)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Hypoxia</td><td styleCode="Botrule Lrule Rrule">8 (10)</td><td styleCode="Botrule Lrule Rrule">4 (5)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Rales</td><td styleCode="Botrule Lrule Rrule">7 (8)</td><td styleCode="Botrule Lrule Rrule">2 (2)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Postnasal drip</td><td styleCode="Botrule Lrule Rrule">4 (5)</td><td styleCode="Botrule Lrule Rrule">2 (2)</td></tr><tr><td colspan="3" styleCode="Botrule Lrule Rrule"><content styleCode="bold">Skin and subcutaneous tissue disorders</content></td></tr><tr><td styleCode="Botrule Lrule Rrule">Ecchymosis</td><td styleCode="Botrule Lrule Rrule">18 (22)</td><td styleCode="Botrule Lrule Rrule">12 (15)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Rash NOS</td><td styleCode="Botrule Lrule Rrule">16 (19)</td><td styleCode="Botrule Lrule Rrule">7 (9)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Erythema</td><td styleCode="Botrule Lrule Rrule">12 (14)</td><td styleCode="Botrule Lrule Rrule">5 (6)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Skin lesion NOS</td><td styleCode="Botrule Lrule Rrule">9 (11)</td><td styleCode="Botrule Lrule Rrule">3 (4)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Pruritis</td><td styleCode="Botrule Lrule Rrule">9 (11)</td><td styleCode="Botrule Lrule Rrule">2 (2)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Alopecia</td><td styleCode="Botrule Lrule Rrule">7 (8)</td><td styleCode="Botrule Lrule Rrule">1 (1)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Urticaria NOS</td><td styleCode="Botrule Lrule Rrule">5 (6)</td><td styleCode="Botrule Lrule Rrule">1 (1)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Swelling face</td><td styleCode="Botrule Lrule Rrule">5 (6)</td><td styleCode="Botrule Lrule Rrule">0 (0)</td></tr><tr><td colspan="3" styleCode="Botrule Lrule Rrule"><content styleCode="bold">Vascular disorders</content></td></tr><tr><td styleCode="Botrule Lrule Rrule">Petechiae</td><td styleCode="Botrule Lrule Rrule">32 (39)</td><td styleCode="Botrule Lrule Rrule">13 (16)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Pallor</td><td styleCode="Botrule Lrule Rrule">19 (23)</td><td styleCode="Botrule Lrule Rrule">10 (12)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Hypotension NOS</td><td styleCode="Botrule Lrule Rrule">5 (6)</td><td styleCode="Botrule Lrule Rrule">4 (5)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Hematoma NOS</td><td styleCode="Botrule Lrule Rrule">4 (5)</td><td styleCode="Botrule Lrule Rrule">3 (4)</td></tr></tbody></table>

<table width="80%"><caption>Table 2 Adverse Reactions Reported in &#x2265; 5% of Patients in a Single-arm Study ^*</caption><col align="left" width="50%"/><col align="center" width="50%"/><thead><tr><th align="center" styleCode="Botrule Lrule Rrule"/><th align="center" styleCode="Botrule Lrule Rrule">Decitabine N = 99 (%) </th></tr></thead><tbody><tr><td colspan="2" styleCode="Botrule Lrule Rrule"><content styleCode="bold">Blood and lymphatic system disorders</content></td></tr><tr><td styleCode="Botrule Lrule Rrule">Anemia</td><td styleCode="Botrule Lrule Rrule">31 (31)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Febrile neutropenia</td><td styleCode="Botrule Lrule Rrule">20 (20)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Leukopenia</td><td styleCode="Botrule Lrule Rrule">6 (6)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Neutropenia</td><td styleCode="Botrule Lrule Rrule">38 (38)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Pancytopenia</td><td styleCode="Botrule Lrule Rrule">5 (5)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Thrombocythemia</td><td styleCode="Botrule Lrule Rrule">5 (5)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Thrombocytopenia</td><td styleCode="Botrule Lrule Rrule">27 (27)</td></tr><tr><td colspan="2" styleCode="Botrule Lrule Rrule"><content styleCode="bold">Cardiac disorders</content></td></tr><tr><td styleCode="Botrule Lrule Rrule">Cardiac failure congestive</td><td styleCode="Botrule Lrule Rrule">5 (5)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Tachycardia</td><td styleCode="Botrule Lrule Rrule">8 (8)</td></tr><tr><td colspan="2" styleCode="Botrule Lrule Rrule"><content styleCode="bold">Ear and labyrinth disorders</content></td></tr><tr><td styleCode="Botrule Lrule Rrule">Ear pain</td><td styleCode="Botrule Lrule Rrule">6 (6)</td></tr><tr><td colspan="2" styleCode="Botrule Lrule Rrule"><content styleCode="bold">Gastrointestinal disorders</content></td></tr><tr><td styleCode="Botrule Lrule Rrule">Abdominal pain</td><td styleCode="Botrule Lrule Rrule">14 (14)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Abdominal pain upper</td><td styleCode="Botrule Lrule Rrule">6 (6)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Constipation</td><td styleCode="Botrule Lrule Rrule">30 (30)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Diarrhea</td><td styleCode="Botrule Lrule Rrule">28 (28)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Dyspepsia</td><td styleCode="Botrule Lrule Rrule">10 (10)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Dysphagia</td><td styleCode="Botrule Lrule Rrule">5 (5)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Gastro-esophageal reflux disease</td><td styleCode="Botrule Lrule Rrule">5 (5)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Nausea</td><td styleCode="Botrule Lrule Rrule">40 (40)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Oral pain</td><td styleCode="Botrule Lrule Rrule">5 (5)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Stomatitis</td><td styleCode="Botrule Lrule Rrule">11 (11)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Toothache</td><td styleCode="Botrule Lrule Rrule">6 (6)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Vomiting</td><td styleCode="Botrule Lrule Rrule">16 (16)</td></tr><tr><td colspan="2" styleCode="Botrule Lrule Rrule"><content styleCode="bold">General disorders and administration site conditions</content></td></tr><tr><td styleCode="Botrule Lrule Rrule">Asthenia</td><td styleCode="Botrule Lrule Rrule">15 (15)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Chest pain</td><td styleCode="Botrule Lrule Rrule">6 (6)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Chills</td><td styleCode="Botrule Lrule Rrule">16 (16)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Fatigue</td><td styleCode="Botrule Lrule Rrule">46 (46)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Mucosal inflammation</td><td styleCode="Botrule Lrule Rrule">9 (9)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Edema</td><td styleCode="Botrule Lrule Rrule">5 (5)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Edema peripheral</td><td styleCode="Botrule Lrule Rrule">27 (27)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Pain</td><td styleCode="Botrule Lrule Rrule">5 (5)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Pyrexia</td><td styleCode="Botrule Lrule Rrule">36 (36)</td></tr><tr><td colspan="2" styleCode="Botrule Lrule Rrule"><content styleCode="bold">Infections and infestations</content></td></tr><tr><td styleCode="Botrule Lrule Rrule">Cellulitis</td><td styleCode="Botrule Lrule Rrule">9 (9)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Oral candidiasis</td><td styleCode="Botrule Lrule Rrule">6 (6)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Pneumonia</td><td styleCode="Botrule Lrule Rrule">20 (20)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Sinusitis</td><td styleCode="Botrule Lrule Rrule">6 (6)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Staphylococcal bacteremia</td><td styleCode="Botrule Lrule Rrule">8 (8)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Tooth abscess</td><td styleCode="Botrule Lrule Rrule">5 (5)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Upper respiratory tract infection</td><td styleCode="Botrule Lrule Rrule">10 (10)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Urinary tract infection</td><td styleCode="Botrule Lrule Rrule">7 (7)</td></tr><tr><td colspan="2" styleCode="Botrule Lrule Rrule"><content styleCode="bold">Injury, poisoning and procedural complications</content></td></tr><tr><td styleCode="Botrule Lrule Rrule">Contusion</td><td styleCode="Botrule Lrule Rrule">9 (9)</td></tr><tr><td colspan="2" styleCode="Botrule Lrule Rrule"><content styleCode="bold">Investigations</content></td></tr><tr><td styleCode="Botrule Lrule Rrule">Blood bilirubin increased</td><td styleCode="Botrule Lrule Rrule">6 (6)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Breath sounds abnormal</td><td styleCode="Botrule Lrule Rrule">5 (5)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Weight decreased</td><td styleCode="Botrule Lrule Rrule">9 (9)</td></tr><tr><td colspan="2" styleCode="Botrule Lrule Rrule"><content styleCode="bold">Metabolism and nutrition disorders</content></td></tr><tr><td styleCode="Botrule Lrule Rrule">Anorexia</td><td styleCode="Botrule Lrule Rrule">23 (23)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Decreased appetite</td><td styleCode="Botrule Lrule Rrule">8 (8)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Dehydration</td><td styleCode="Botrule Lrule Rrule">8 (8)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Hyperglycemia</td><td styleCode="Botrule Lrule Rrule">6 (6)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Hypokalemia</td><td styleCode="Botrule Lrule Rrule">12 (12)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Hypomagnesemia</td><td styleCode="Botrule Lrule Rrule">5 (5)</td></tr><tr><td colspan="2" styleCode="Botrule Lrule Rrule"><content styleCode="bold">Musculoskeletal and connective tissue disorders</content></td></tr><tr><td styleCode="Botrule Lrule Rrule">Arthralgia</td><td styleCode="Botrule Lrule Rrule">17 (17)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Back pain</td><td styleCode="Botrule Lrule Rrule">18 (18)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Bone pain</td><td styleCode="Botrule Lrule Rrule">6 (6)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Muscle spasms</td><td styleCode="Botrule Lrule Rrule">7 (7)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Muscular weakness</td><td styleCode="Botrule Lrule Rrule">5 (5)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Musculoskeletal pain</td><td styleCode="Botrule Lrule Rrule">5 (5)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Myalgia</td><td styleCode="Botrule Lrule Rrule">9 (9)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Pain in extremity</td><td styleCode="Botrule Lrule Rrule">18 (18)</td></tr><tr><td colspan="2" styleCode="Botrule Lrule Rrule"><content styleCode="bold">Nervous system disorders</content></td></tr><tr><td styleCode="Botrule Lrule Rrule">Dizziness</td><td styleCode="Botrule Lrule Rrule">21 (21)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Headache</td><td styleCode="Botrule Lrule Rrule">23 (23)</td></tr><tr><td colspan="2" styleCode="Botrule Lrule Rrule"><content styleCode="bold">Psychiatric disorders</content></td></tr><tr><td styleCode="Botrule Lrule Rrule">Anxiety</td><td styleCode="Botrule Lrule Rrule">9 (9)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Confusional state</td><td styleCode="Botrule Lrule Rrule">8 (8)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Depression</td><td styleCode="Botrule Lrule Rrule">9 (9)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Insomnia</td><td styleCode="Botrule Lrule Rrule">14 (14)</td></tr><tr><td colspan="2" styleCode="Botrule Lrule Rrule"><content styleCode="bold">Respiratory, thoracic and mediastinal disorders</content></td></tr><tr><td styleCode="Botrule Lrule Rrule">Cough</td><td styleCode="Botrule Lrule Rrule">27 (27)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Dyspnea</td><td styleCode="Botrule Lrule Rrule">29 (29)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Epistaxis</td><td styleCode="Botrule Lrule Rrule">13 (13)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Pharyngolaryngeal pain</td><td styleCode="Botrule Lrule Rrule">8 (8)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Pleural effusion</td><td styleCode="Botrule Lrule Rrule">5 (5)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Sinus congestion</td><td styleCode="Botrule Lrule Rrule">5 (5)</td></tr><tr><td colspan="2" styleCode="Botrule Lrule Rrule"><content styleCode="bold">Skin and subcutaneous tissue disorders</content></td></tr><tr><td styleCode="Botrule Lrule Rrule">Dry skin</td><td styleCode="Botrule Lrule Rrule">8 (8)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Ecchymosis</td><td styleCode="Botrule Lrule Rrule">9 (9)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Erythema</td><td styleCode="Botrule Lrule Rrule">5 (5)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Night sweats</td><td styleCode="Botrule Lrule Rrule">5 (5)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Petechiae</td><td styleCode="Botrule Lrule Rrule">12 (12)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Pruritus</td><td styleCode="Botrule Lrule Rrule">9 (9)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Rash</td><td styleCode="Botrule Lrule Rrule">11 (11)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Skin lesion</td><td styleCode="Botrule Lrule Rrule">5 (5)</td></tr><tr><td colspan="2" styleCode="Botrule Lrule Rrule"><content styleCode="bold">Vascular disorders</content></td></tr><tr><td styleCode="Botrule Lrule Rrule">Hypertension</td><td styleCode="Botrule Lrule Rrule">6 (6)</td></tr><tr><td styleCode="Botrule Lrule Rrule">Hypotension</td><td styleCode="Botrule Lrule Rrule">11 (11)</td></tr></tbody></table>